Who owns ATARA BIOTHERAPEUTICS INC?
- Ticker: ATRA
- CUSIP Number: 046513206
Tip: Access positions for across all investors
Analyze quarterly positions in Atara Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atara Biotherapeutics stock
Who bought or sold ATARA BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Redmile Group | 452k | $3.7M | 0% | Sep 2024 |
|
| EcoR1 Capital | 407k | $3.5M | 100% | Jun 2024 |
|
| Citadel Advisors | 261k | $2.1M | 0% | Sep 2024 |
|
| Bank of America Corporation | 204k | $1.7M | 9% | Sep 2024 |
|
| Vanguard Group | 169k | $1.4M | 100% | Jun 2024 |
|
| Acadian Asset Management | 129k | $1.0M | 8% | Sep 2024 |
|
| Vestal Point Capital | 125k | $1.0M | 11% | Sep 2024 |
|
| Qube Research & Technologies | 103k | $873k | 100% | Jun 2024 |
|
| Tang Capital Management | 75k | $611k | 0% | Sep 2024 |
|
| Renaissance Technologies | 68k | $551k | 47% | Sep 2024 |
|
| BlackRock | 61k | $520k | 100% | Jun 2024 |
|
| BlackRock | 61k | $496k | 100% | Sep 2024 |
|
| Geode Capital Management | 47k | $380k | 9% | Sep 2024 |
|
| Centiva Capital | 43k | $353k | -69% | Sep 2024 |
|
| Staley Capital Advisers | 40k | $325k | 0% | Sep 2024 |
|
| State Street Corporation | 15k | $125k | 100% | Jun 2024 |
|
| Bridgeway Capital Management | 14k | $119k | 100% | Jun 2024 |
|
| Morgan Stanley | 9.8k | $83k | 100% | Jun 2024 |
|
| Tower Research Capital | 4.5k | $38k | 100% | Jun 2024 |
|
| Jpmorgan Chase & Co | 1.4k | $11k | -17% | Sep 2024 |
|
| Wells Fargo & Company | 1.3k | $10k | 297% | Sep 2024 |
|
| Global Retirement Partners | 750.00 | $6.1k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 644.00 | $5.2k | 100% | Sep 2024 |
|
| Group One Trading | 394.00 | $3.2k | -92% | Sep 2024 |
|
| Macquarie Group | 197.00 | $1.7k | 100% | Jun 2024 |
|
| IFP Advisors | 180.00 | $1.5k | 100% | Jun 2024 |
|
| Rhumbline Advisers | 175.00 | $1.4k | -74% | Sep 2024 |
|
| Lazard Asset Management | 129.00 | $999.995100 | -58% | Sep 2024 |
|
| Catalyst Funds Management Pty | 100.00 | $850.000000 | 100% | Jun 2024 |
|
| Bnp Paribas Arbitrage, Snc | 56.00 | $455.000000 | -100% | Sep 2024 |
|
| GAMMA Investing | 56.00 | $455.000000 | 100% | Sep 2024 |
|
| Royal Bank of Canada | 17.00 | $0 | -99% | Sep 2024 |
|
| Citigroup | 8.00 | $65.000000 | -100% | Sep 2024 |
|
| Russell Investments | 2.00 | $17.000000 | 100% | Jun 2024 |
|
Who sold out of Atara Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 117k | $992k |
| Woodline Partners | Jun 2024 | 71k | $603k |
| Charles Schwab Investment Management | Jun 2024 | 26k | $222k |
| AQR Capital Management | Jun 2024 | 15k | $128k |
| Susquehanna International | Jun 2024 | 15k | $123k |
| Cubist Systematic Strategies | Jun 2024 | 9.3k | $79k |
| Point72 Asia | Jun 2024 | 6.3k | $54k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 1.9k | $16k |
| Federated Investors | Jun 2024 | 57.00 | $485.001600 |
| New York State Common Retirement Fund | Jun 2024 | 32.00 | $0 |